(Q24301134)

GOA release 2020-03-11

drug binding

1 reference

GOA release 2020-03-11

author name string

Carlo Bertucci

1

0 references

Samanta Cimitan

2

0 references

Antonella Riva

3

0 references

Paolo Morazzoni

Journal of Pharmaceutical and Biomedical Analysis

4

0 references

language of work or name

English

0 references

publication date

11 September 2006

0 references

published in

0 references

volume

42

0 references

issue

1

0 references

page(s)

81-7

0 references

cites work

Use of a human serum albumin-based stationary phase for high-performance liquid chromatography as a tool for the rapid determination of drug-plasma protein binding

1 reference

https://api.crossref.org/works/10.1016%2FJ.JPBA.2005.12.002

7 January 2021

Alcohol-induced molten globule intermediates of proteins: are they real folding intermediates or off pathway products?

1 reference

https://api.crossref.org/works/10.1016%2FJ.JPBA.2005.12.002

7 January 2021

Stability of phage T4 lysozymes. I. Native properties and thermal stability of wild type and two mutant lysozymes

1 reference

https://api.crossref.org/works/10.1016%2FJ.JPBA.2005.12.002

7 January 2021

Development and validation of a method to determine the unbound paclitaxel fraction in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FJ.JPBA.2005.12.002

7 January 2021

Paclitaxel-HSA interaction. Binding sites on HSA molecule.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JPBA.2005.12.002

7 January 2021

Analysis of conformational change of human serum albumin using chiral capillary electrophoresis

1 reference

https://api.crossref.org/works/10.1016%2FJ.JPBA.2005.12.002

7 January 2021

Conformation changes of albumin in its interaction with physiologically active compounds as studied by quasi-elastic light scattering spectroscopy and ultrasonic method

1 reference

https://api.crossref.org/works/10.1016%2FJ.JPBA.2005.12.002

7 January 2021

Interaction of taxol with human serum albumin.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JPBA.2005.12.002

7 January 2021

Synthesis and HSA binding characterisation of the water soluble 7-succinylpaclitaxel

1 reference

https://api.crossref.org/works/10.1016%2FJ.JPBA.2005.12.002

7 January 2021

High-performance affinity chromatography: a powerful tool for studying serum protein binding

1 reference

https://api.crossref.org/works/10.1016%2FJ.JPBA.2005.12.002

7 January 2021

Early Absorption and Distribution Analysis of Antitumor and Anti-AIDS Drugs: Lipid Membrane and Plasma Protein Interactions

1 reference

https://api.crossref.org/works/10.1016%2FJ.JPBA.2005.12.002

7 January 2021

High affinity binding of paclitaxel to human serum albumin

1 reference

https://api.crossref.org/works/10.1016%2FJ.JPBA.2005.12.002

7 January 2021

Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine

1 reference

https://api.crossref.org/works/10.1016%2FJ.JPBA.2005.12.002

7 January 2021

Displacement of valproic acid and carbamazepine from protein binding in normal and uremic sera by tolmetin, ibuprofen, and naproxen: presence of inhibitor in uremic serum that blocks valproic acid-naproxen interactions

1 reference

https://api.crossref.org/works/10.1016%2FJ.JPBA.2005.12.002

7 January 2021

How chronically administered valproate increases chlordiazepoxide transfer through the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FJ.JPBA.2005.12.002

7 January 2021

The seco-taxane IDN5390 is able to target class III beta-tubulin and to overcome paclitaxel resistance.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JPBA.2005.12.002

7 January 2021

Reversible and covalent binding of drugs to human serum albumin: methodological approaches and physiological relevance

1 reference

https://api.crossref.org/works/10.1016%2FJ.JPBA.2005.12.002

7 January 2021